Response to the randomized trial of recombinant human erythropoietin in critically ill patients
- PMID: 17522548
- DOI: 10.1097/01.CCM.0000266837.49803.D0
Response to the randomized trial of recombinant human erythropoietin in critically ill patients
Comment on
-
Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.Crit Care Med. 2006 Sep;34(9):2310-6. doi: 10.1097/01.CCM.0000233873.17954.42. Crit Care Med. 2006. PMID: 16878035 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
